GammaDelta Therapeutics announced as winner of the 2018 Outstanding Achievement Award at the OBN Annual Awards Ceremony.

Tim Haines

Board Member

Tim Haines is a Managing Partner at Abingworth. Tim has more than 25 years of international management experience in the life sciences industry at both public and private companies. During his time at Abingworth Tim has taken board roles in a number ofcompanies including Astex, Fovea, Lombard Medical, MEDIAN Technologies, PixiumVision, PowderMed, Proteon, Sientra and Stanmore Implants. Before joining Abingworth in 2005 he was CEO of the Abingworth portfolio company, Astex Therapeutics.

Tim was with Astex for more than five years and was instrumental in establishing it as one of the leading UK biotechnology companies. Previously, Tim was Chief Executive of two divisions of the publicly-listed medical technology company, Datascope Corp. Prior to Datascope, he held a number of other senior management positions in the US and Europe, including CEO of Thackray Inc and General Manager Baxter UK. Tim has a BSC from Exeter University and an MBA from INSEAD.